• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Upcoming dvm360 Conferences
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
Veterinary Heroes
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

CVC Highlights: Optimizing antimicrobial therapy

October 1, 2005
Robert L. Bill, DVM, MS, PhD

To reduce the potential for developing bacterial resistance, it is important to follow treatment guidelines that help ensure elimination of the microbial population.

Robert L. Bill, DVM, MS, PhD, Basic Medical Science, School of Veterinary Medicine, Purdue University, West Lafayette, IN 47907.

To reduce the potential for developing bacterial resistance, it is important to follow treatment guidelines that help ensure elimination of the microbial population. The primary principle of successful antimicrobial therapy is to establish an adequate concentration of an antimicrobial that the organism is susceptible to at the infection site. Prudent antimicrobial selection includes correctly identifying the therapeutic needs of the animal (e.g. bacterial vs. viral infection), adjusting therapy in accord with the physiological state of the animal (e.g. bacteriostatic drugs rely on an animal's intact immune system to eliminate the pathogen), and understanding the drug's characteristics (e.g. aminoglycosides won't penetrate tissues with cellular barriers). Failure to consider all these factors can result in therapeutic failure or potentially severe adverse reactions.

Robert L. Bill, DVM, MS, PhD

Advertisement

When treating bacterial infections, keep in mind that if the inflammatory reaction to the primary pathogen has caused marked pathology, antimicrobial therapy alone may not alleviate the clinical condition. For example, a patient may become hypoxemic and die of pulmonary edema that arises secondary to inflammation associated with the bacterial infection. With few exceptions (e.g. sulfasalazine), antimicrobials will not directly reduce inflammatory components of disease. Treating the clinical signs in the short term may be as important as eliminating the infection.

In general, antimicrobials can be classified into three tiers. The antimicrobials in the first tier, or first line of defense, are selected based on whether the infections are empirically susceptible to commonly used older antimicrobials that have a narrower spectrum of coverage (compared with second- and third-tier drugs). These drugs include amoxicillin or amoxicillin with clavulanate, first-generation cephalosporins, trimethoprim-sulfadiazine, and tetracyclines.

The second-tier antimicrobials are selected based on an antimicrobial's extended spectrum of coverage (compared with first-tier drugs) and are reserved for those infections likely to be resistant to first-line drugs. Drugs included in the second tier are second- and third-generation cephalosporins, fluoroquinolones, lincosamides, oxacillin, and aminoglycosides.

The third tier of antimicrobials is selected based on the need to reserve certain drugs because of their importance to animal or human health and to select drugs for those infections that are documented to be resistant to first- and second-tier drugs. Drugs included in this category are the extended-spectrum penicillins, vancomycin, and imipenem-cilastatin.

Acute infections are treated for three days after clinical signs resolve. For chronic infections, extend treatment for three to six weeks depending on the organism, the site of infection (e.g. whether the drug can readily reach the site), and an estimation of the physiological changes that have occurred at the infection site that may interfere with the antimicrobial's ability to work (e.g. increased permeability of the blood-brain barrier to hydrophilic drugs during active inflammation followed by reduced permeability as the inflammation subsides).

SUGGESTED READING

1. Morley PS, Apley MD, Besser TE, et al. Antimicrobial drug use in veterinary medicine. J Vet Intern Med 2005;19:617-629.

Attendees selected this highlight from CVC lectures. The original paper was published in the proceedings of the 2005 Central Veterinary Conference.

Related Content:

Infectious Diseases
Veterinary infectious diseases in 2023: Will the surge continue?
Veterinary infectious diseases in 2023: Will the surge continue?
Every veterinarian must care about African swine fever
Every veterinarian must care about African swine fever
The 5 deadliest zoonotic diseases and pathogens
The 5 deadliest zoonotic diseases and pathogens

Advertisement

Latest News

The Vets appoints Dr Zach Mills to VP of Medical Performance

Communicating the importance of genetic screening

Purina announces its 2023 Pet Care Innovation Prize winners

AmeriVet Veterinary Partners deemed a 2022 Business of the Year

View More Latest News
Advertisement